Jane Street’s Kura Oncology KURA Stock Holding History

Jane Street’s Portfolio KURA Stock Details KURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$293K	Buy	+36,100	New	+$310K	﹤0.01%	9279
2025 Q4	–	Sell	-15,400	Closed	-$136K	–	11824
2025 Q3	$136K	Buy	+15,400	New	+$110K	﹤0.01%	9951
2022 Q1	–	Sell	-13,400	Closed	-$188K	–	10691
2021 Q4	$188K	Buy	13,400 +1,100	+9%	+$17.8K	﹤0.01%	8859
2021 Q3	$230K	Buy	+12,300	New	+$232K	﹤0.01%	8646
2021 Q1	–	Sell	-41,000	Closed	-$1.34M	–	9378
2020 Q4	$1.34M	Sell	41,000 -35,000	-46%	-$1.23M	﹤0.01%	4191
2020 Q3	$2.33M	Buy	+76,000	New	+$1.68M	﹤0.01%	2805

Other funds holding KURA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jane Street's KURA Position: Q1 2026 in Review

Jane Street increased its Kura Oncology (KURA) stake by 39% in Q1 2026, buying an estimated $1.6M and bringing the position to 663,350 shares worth $5.39M. The position accounts for ﹤0.01% of the portfolio, ranked #3397.

Jane Street first reported a position in KURA in Q2 2019 and has held it in 23 quarters since. 220 funds tracked by Wall St. Rank hold KURA as of Q1 2026.

Jane Street held 663,350 shares of Kura Oncology worth $5.39M as of Q1 2026.
Jane Street bought 186,205 Kura Oncology shares in Q1 2026, an estimated $1.6M.
Kura Oncology made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #3397 holding.
Jane Street first reported a position in Kura Oncology in Q2 2019 and has held it in 23 quarters since.
220 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.